William E. Rote, SENIOR VICE PRESIDENT, R&D at Travere Therapeutics, Inc. (TVTX), sold 5,200 shares at $23.53 ($122K) on 2025-02-12, disclosed to the SEC on 2025-02-12.
Scheduled sale ($122k) by SENIOR VICE PRESIDENT, R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TVTX | SELL | 2026-04-23 | $356K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $409K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $2.4M | — | Filing → |